QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN)
CUSIP: 74754R103
Q4 2020 13F Holders as of 31 Dec 2020
- Type / Class
- Equity / Common Stock, par value $0.001 per share
- Shares outstanding
- 6,138,804
- Total 13F shares
- 1,190,365
- Share change
- +364,465
- Total reported value
- $3,582,482
- Put/Call ratio
- 241%
- Price per share
- $3.01
- Number of holders
- 25
- Value change
- +$1,037,310
- Number of buys
- 17
- Number of sells
- 5
Quarterly Holders Quick Answers
What is CUSIP 74754R103?
CUSIP 74754R103 identifies QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74754R103:
Top shareholders of QLGN - QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
5.1%
|
314,126
|
$1,555,000 | — | 30 Sep 2020 | |
| VANGUARD GROUP INC |
13F
|
Company |
5%
|
305,951
|
$1,515,000 | — | 30 Sep 2020 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.1%
|
66,306
|
$328,000 | — | 30 Sep 2020 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.87%
|
53,687
|
$266,000 | — | 30 Sep 2020 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.4%
|
24,768
|
$123,000 | — | 30 Sep 2020 | |
| Cetera Investment Advisers |
13F
|
Company |
0.27%
|
16,765
|
$83,000 | — | 30 Sep 2020 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.25%
|
15,420
|
$77,000 | — | 30 Sep 2020 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
5,600
|
$27,000 | — | 30 Sep 2020 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
2,940
|
$14,000 | — | 30 Sep 2020 | |
| Retirement Group, LLC |
13F
|
Company |
0.03%
|
2,000
|
$10,000 | — | 30 Sep 2020 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
1,061
|
$5,000 | — | 30 Sep 2020 | |
| PNC FINANCIAL SERVICES GROUP, INC. |
13F
|
Company |
0.02%
|
1,000
|
$5,000 | — | 30 Sep 2020 | |
| Your Advocates Ltd., LLP |
13F
|
Company |
0%
|
200
|
$1,000 | — | 30 Sep 2020 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
116
|
$1,000 | — | 30 Sep 2020 | |
| Archer Investment Corp |
13F
|
Company |
0%
|
160
|
$792 | — | 30 Sep 2020 |
Institutional Holders of QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) as of Q4 2020
As of 31 Dec 2020,
QUALIGEN THERAPEUTICS, INC. - Common Stock, par value $0.001 per share (QLGN) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,190,365 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, QS Investors, LLC, SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC, CITADEL ADVISORS LLC, Cetera Investment Advisers, NORTHERN TRUST CORP, WEDBUSH SECURITIES INC, and WELLS FARGO & COMPANY/MN.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2020 vs Q3 2020 Across Filers
Q3 2020 holders
15
Q4 2020 holders
25
Holder diff
10
| Investor | Q3 2020 Shares | Q4 2020 Shares | Share Diff | Share Chg % | Q3 2020 Value $ | Q4 2020 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.